Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
India
Manufacturing
FDA hands warning letters to manufacturers in China, India
A manufacturer of drug ingredients in Tianjin, China has also run afoul of the regulator in a new round of facility writeups.
Fraiser Kansteiner
Aug 19, 2026 10:20am
Generic tariffs, Samsung Bio, HK IPO—Fierce Pharma Asia
Jul 24, 2026 9:00am
FDA rebukes two Indian API makers in pair of warning letters
Jul 23, 2026 9:32am
Fierce Biotech
How India can build on its budding innovative R&D moment: report
Jul 23, 2026 5:00am
Alembic site hit with warning letter on patient consent concerns
Jul 21, 2026 11:40am
Dr. Reddy's temporarily pauses generic semaglutide supplies
Jul 9, 2026 8:48am
